Want to join the conversation?
In 2Q16, $JPM's Corporate & Investment Bank (CIB) segment posted net income of $2.5Bil on revenue of $9.2Bil and an ROE of 15%. In banking, IB revenue was $1.5Bil, down 15% largely driven by lower equity underwriting fees. Advisory fees were flat vs. a wallet that declined 15%. The company grew share for this segment by 50 BP.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?